Shopping Cart

Your shopping cart is currently empty

CpCDPK1/TgCDPK1-IN-1

Name: CpCDPK1/TgCDPK1-IN-1
Brand: TargetMol
SKU: T78605
Price: 245 USD
Availability: InStock
Rating: 5 (10 reviews)

Catalog No. T78605 Copy Product Info

Purity: 99.98%

🥰Excellent

CpCDPK1/TgCDPK1-IN-1 is a potent dual inhibitor of CpCDPK1 and TgCDPK1, inhibits Abl and Src, and has antiparasitic activity for the study of Toxoplasma infections and cryptosporidiosis.

CpCDPK1/TgCDPK1-IN-1

Copy Product Info

🥰Excellent

Catalog No. T78605

CpCDPK1/TgCDPK1-IN-1 is a potent dual inhibitor of CpCDPK1 and TgCDPK1, inhibits Abl and Src, and has antiparasitic activity for the study of Toxoplasma infections and cryptosporidiosis.

Cas No. 1092788-23-2

Customer service consultation

Pack Size	Price	USA Stock	Global Stock
1 mg	$245	-	In Stock
5 mg	$679	-	In Stock
10 mg	$813	-	In Stock
25 mg	$1,020	-	In Stock

For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)

Add to Cart

Add to Quotation

Custom-made molecule. TargetMol’s expert synthesis team delivers cost-effective solutions. Contact us for inquiries. Committed to serving you.

For research use only—not for human use. No sales to individuals. Use as intended only.

Questions

Batch Information

Select Batch

Purity:99.98%

Appearance:Solid

Color:Yellow

Resource Download

COA LCMS HNMR

Product Introduction

CpCDPK1/TgCDPK1-IN-1 AI Summary

CpCDPK1/TgCDPK1-IN-1 exhibits bioactivity as a potent multi-target inhibitor. It effectively inhibits multiple PI3K isoforms (PI3Kalpha, PI3Kbeta, PI3Kdelta, PI3Kgamma) with IC50 values ranging from 1200.0 nM to 32000.0 nM, and displays significant inhibitory activity against DNA-PK with an IC50 value of 200.0 nM. Additionally, it has remarkable inhibitory effects on pathogens such as Cryptosporidium parvum and Toxoplasma gondii, with IC50 values of 10.0 nM and 5.0 nM, respectively. CpCDPK1/TgCDPK1-IN-1 also demonstrates potent inhibition in kinase assays against Toxoplasma gondii CDPK1, Cryptosporidium parvum CDPK1, human SRC, and human ABL kinases, highlighting its potential therapeutic applications in targeting these enzymes..

Note: Summary generated by AI. Data source: ChEMBL

Bioactivity

Description	CpCDPK1/TgCDPK1-IN-1 is a potent dual inhibitor of CpCDPK1 and TgCDPK1, inhibits Abl and Src, and has antiparasitic activity for the study of Toxoplasma infections and cryptosporidiosis.
Targets&IC50	CpCDPK1:10 nM, TgCDPK1:5.0 nM

Chemical Properties

Molecular Weight	303.36
Formula	C₁₈H₁₇N₅
Cas No.	1092788-23-2
Smiles	N=1C=NC2=C(C1N)C(=NN2C(C)C)C=3C=CC=4C=CC=CC4C3

Storage & Solubility Information

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Solubility Information

DMSO: 100 mg/mL (329.64 mM), Sonication is recommended.

Solution Preparation Table

DMSO

	1mg	5mg	10mg	50mg
1 mM	3.2964 mL	16.4821 mL	32.9641 mL	164.8207 mL
5 mM	0.6593 mL	3.2964 mL	6.5928 mL	32.9641 mL
10 mM	0.3296 mL	1.6482 mL	3.2964 mL	16.4821 mL
20 mM	0.1648 mL	0.8241 mL	1.6482 mL	8.2410 mL
50 mM	0.0659 mL	0.3296 mL	0.6593 mL	3.2964 mL
100 mM	0.0330 mL	0.1648 mL	0.3296 mL	1.6482 mL

Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:

For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments

and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent

10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH₂O , the resulting working solution concentration would be 2 mg/mL.

Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSO TargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSO TargetMol | reagent stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH₂O TargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.

All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc